We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

Global Patient Derived Xenograft/PDX Models Market

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

The global Patient Derived Xenograft/PDX Models Market was valued at USD 66.9 million in 2016 and is projected to reach USD 256.40million by 2025, growing at a CAGR of 16.1% from 2017 to 2025.
Patient derived tumor xenografts (PDTX) are created when cancerous tissue from a patient's primary tumor is implanted directly into an immunodeficient mouse. PDTX models are providing solutions to the challenges that researchers face in cancer drug research such as positive tumor responses in mouse models but not translating over when the study is implemented in humans. As a result, PDTX cancer models are becoming popular models to use in cancer drug research.
Sample Infographics:


Market Dynamics:
1. Market Drivers
1.1 Increasing Demand for Personalizes healthcare
1.2 GrowingInvestment in Cancer studies from private as well as govt. Sector
1.3 Growing R&D activities

2. Market Restraints
2.1 High cost of PDX models
2.2 Clinical Testing Stringent rules and ethical issues

Market Segmentation:
1. Global Patient Derived Xenograft/PDX Models Market, by Tumor type:
1.1 Gastrointestinal Tumor Models
1.2 Gynecological Tumor Models
1.3 Respiratory Tumor Models
1.4 Urological Tumor Models
1.5 Hematological Tumor Models
1.6 Other Tumor Models

2. Global Patient Derived Xenograft/PDX Models Market, by Type:
2.1 Rat Models
2.2 Mice Models

3. Global Patient Derived Xenograft/PDX Models Market, by End User:
3.1 Pharmaceutical & Biotechnology Companies
3.2 Contract Research Organizations
3.3 Academic & Research Institutions

4. Global Patient Derived Xenograft/PDX Models Market, by Application:
4.1 Preclinical Drug Development and Basic Cancer Research
4.2 Biomarker Analysis

5. Global Patient Derived Xenograft/PDX Models Market, by Region:
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (Germany, UK, France, Rest of Europe)
5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
5.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. Crown Bioscience Inc.
2. the Jackson Laboratory
3. Champions Oncology, Inc.
4. Charles River Laboratories International, Inc.
5. WuXiApptec (Group of Subsidiaries Under WuXiPharmatec)
6. ONCODESIGN
7. Horizon Discovery Group PLC (Sage Labs, Inc.)
8. Pharmatest Services Ltd.
9. Hera Biolabs
10. EPO Berlin-Buch GmbH
11. Xentech
12. Urolead
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Patient Derived Xenograft/PDX Models Marketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.

1 INTRODUCTION OF GLOBAL PATIENT DERIVED XENOGRAFT/PDX MODELS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL PATIENT DERIVED XENOGRAFT/PDX MODELS MARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL PATIENT DERIVED XENOGRAFT/PDX MODELS MARKET, BY TUMOR TYPE
5.1 Overview
5.2 Gastrointestinal Tumor Models
5.3 Gynecological Tumor Models
5.4 Respiratory Tumor Models
5.5 Urological Tumor Models
5.6 Hematological Tumor Models
5.7 Others

6 GLOBAL PATIENT DERIVED XENOGRAFT/PDX MODELS MARKET, BY TYPE
6.1 Overview
6.2 Rat Models
6.3 Mice Models

7 GLOBAL PATIENT DERIVED XENOGRAFT/PDX MODELS MARKET, BY END USER
7.1 Overview
7.2 Pharmaceutical & Biotechnology Companies
7.3 Contract Research Organizations
7.4 Academic & Research Institutions

8 GLOBAL PATIENT DERIVED XENOGRAFT/PDX MODELS MARKET, BY APPLICATION
8.1 Overview
8.2 Preclinical Drug Development and Basic Cancer Research
8.3 Biomarker Analysis

9 GLOBAL PATIENT DERIVED XENOGRAFT/PDX MODELS MARKET, BY GEOGRAPHY
9.1 Overview
9.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025

10 GLOBAL PATIENT DERIVED XENOGRAFT/PDX MODELS MARKETCOMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies

11 COMPANY PROFILES
11.1 Crown Bioscience Inc.
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments

11.2 The Jackson Laboratory
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments

11.3 Champions Oncology, Inc.
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments

11.4 Charles River Laboratories International, Inc.
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments

11.5 WuXiApptec
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments

11.6 ONCODESIGN
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments

11.7 Horizon Discovery Group PLC
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments

11.8 Pharmatest Services Ltd.
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments

11.9 Hera Biolabs
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments

11.10 EPO Berlin-Buch GmbH
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments

11.11 Xentech
11.11.1 Overview
11.11.2 Financial Performance
11.11.3 Product Outlook
11.11.4 Key Developments

11.12 Urolead
11.12.1 Overview
11.12.2 Financial Performance
11.12.3 Product Outlook
11.12.4 Key Developments

12 Appendix
12.1 Related Reports

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved